|
|
Volumn 65, Issue 5, 2000, Pages 331-336
|
|
Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma
a
|
|
Author keywords
2 Microglobulin; Bisphosphonates; Bone alkaline phosphatase; Cross linked N telopeptides of type I collagen (NTx); Interleukin 6; Multiple myeloma; Osteocalcin; Pamidronate; Paraprotein
|
|
Indexed keywords
ALKALINE PHOSPHATASE BONE ISOENZYME;
BETA 2 MICROGLOBULIN;
BISPHOSPHONIC ACID DERIVATIVE;
C REACTIVE PROTEIN;
COLLAGEN TYPE 1;
DOXORUBICIN;
INTERLEUKIN 6;
METHOTREXATE;
OSTEOCALCIN;
PAMIDRONIC ACID;
PARAPROTEIN;
PREDNISONE;
VINBLASTINE;
ADULT;
AGED;
ANALGESIA;
ARTICLE;
BONE TURNOVER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE MARKER;
DRUG POTENTIATION;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE MYELOMA;
MULTIVARIATE ANALYSIS;
OSTEOCLAST;
OSTEOLYSIS;
PAIN;
PAIN ASSESSMENT;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SALVAGE THERAPY;
STATISTICAL ANALYSIS;
AGED;
ALKALINE PHOSPHATASE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BETA 2-MICROGLOBULIN;
BIOLOGICAL MARKERS;
BONE REMODELING;
BONE RESORPTION;
C-REACTIVE PROTEIN;
COLLAGEN;
COLLAGEN TYPE I;
DIPHOSPHONATES;
DRUG EVALUATION;
FEMALE;
HUMANS;
INTERLEUKIN-6;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
MULTIVARIATE ANALYSIS;
OSTEOCALCIN;
PAIN MEASUREMENT;
PARAPROTEINS;
PEPTIDES;
TIME FACTORS;
|
|
EID: 0033744201
PISSN: 09024441
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0609.2000.065005331.x Document Type: Article |
|
Times cited : (64)
|
|
References (26)
|
